Par Drugs And Chemicals Limited (PAR) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.076x

Based on the latest financial reports, Par Drugs And Chemicals Limited (PAR) has a cash flow conversion efficiency ratio of 0.076x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs80.95 Million ≈ $875.41K USD) by net assets (Rs1.06 Billion ≈ $11.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Par Drugs And Chemicals Limited liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Par Drugs And Chemicals Limited - Cash Flow Conversion Efficiency Trend (2016–2026)

This chart illustrates how Par Drugs And Chemicals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Par Drugs And Chemicals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Par Drugs And Chemicals Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Zacatecas Silver Corp V:ZAC	-0.018x
Tellusgruppen AB ST:TELLUS	5.086x
Salutica Bhd KLSE:0183	-0.102x
Emova Group SA PA:ALEMV	0.190x
PATERSON RESOURCES LTD F:U40	N/A
Biovie Inc NASDAQ:BIVI	-0.477x
Taoping Inc NASDAQ:TAOP	-0.038x
Strategic Resources Inc V:SR	-0.008x

Annual Cash Flow Conversion Efficiency for Par Drugs And Chemicals Limited (2016–2026)

The table below shows the annual cash flow conversion efficiency of Par Drugs And Chemicals Limited from 2016 to 2026. For the full company profile with market capitalisation and key ratios, see PAR market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs1.12 Billion ≈ $12.11 Million	Rs164.32 Million ≈ $1.78 Million	0.147x	-10.13%
2025-03-31	Rs989.75 Million ≈ $10.70 Million	Rs161.60 Million ≈ $1.75 Million	0.163x	-30.95%
2024-03-31	Rs856.32 Million ≈ $9.26 Million	Rs202.49 Million ≈ $2.19 Million	0.236x	+25.93%
2023-03-31	Rs712.38 Million ≈ $7.70 Million	Rs133.77 Million ≈ $1.45 Million	0.188x	+47.65%
2022-03-31	Rs598.77 Million ≈ $6.48 Million	Rs76.15 Million ≈ $823.55K	0.127x	-45.05%
2021-03-31	Rs522.15 Million ≈ $5.65 Million	Rs120.85 Million ≈ $1.31 Million	0.231x	+22.22%
2020-03-31	Rs406.15 Million ≈ $4.39 Million	Rs76.91 Million ≈ $831.77K	0.189x	-27.23%
2019-03-31	Rs291.17 Million ≈ $3.15 Million	Rs75.77 Million ≈ $819.45K	0.260x	+24.73%
2018-03-31	Rs206.99 Million ≈ $2.24 Million	Rs43.18 Million ≈ $467.01K	0.209x	-56.32%
2017-03-31	Rs192.03 Million ≈ $2.08 Million	Rs91.72 Million ≈ $991.96K	0.478x	+27.00%
2016-03-31	Rs173.56 Million ≈ $1.88 Million	Rs65.27 Million ≈ $705.91K	0.376x	--

About Par Drugs And Chemicals Limited

NSE:PAR India Drug Manufacturers - Specialty & Generic

Market Cap

$12.83 Million

Rs1.19 Billion INR

Market Cap Rank

#26415 Global

#1470 in India

Share Price

Rs96.40

Change (1 day)

+1.62%

52-Week Range

Rs78.58 - Rs118.56

All Time High

Rs348.45